Development of selective inhibitors for anti-apoptotic Bcl-2 proteins from BHI-1.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2007-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BMC.2006.12.020PMID 17227711PMCID PMC2001163
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An inhibitor of Bcl-2 family proteins induces regression of solid tumours

  2005cited by this paper
• Paralog-selective ligands for bcl-2 proteins.

  2005cited by this paper
• Solution Structure of Prosurvival Mcl-1 and Characterization of Its Binding by Proapoptotic BH3-only Ligands*

  2005cited by this paper
• Modulation of tamoxifen sensitivity by antisense Bcl‐2 and trastuzumab in breast carcinoma cells

  2005cited by this paper
• Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function.

  2005cited by this paper
• Bcl-2 family members and disease.

  2004cited by this paper
• Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization.

  2004cited by this paper
• Bcl-2 family gene modulation during spontaneous apoptosis of B-chronic lymphocytic leukemia cells.

  2004cited by this paper
• Breast Cancer Cells Can Evade Apoptosis-Mediated Selective Killing by a Novel Small Molecule Inhibitor of Bcl-2

  2004cited by this paper
• Structural biology of the Bcl-2 family of proteins.

  2004cited by this paper
• Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix

  2004cited by this paper
• Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mapping.

  2003cited by this paper
• Identification of Chelerythrine as an Inhibitor of BclXL Function*

  2003cited by this paper
• Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosis.

  2003cited by this paper
• Bcl-w is expressed in a majority of infiltrative gastric adenocarcinomas and suppresses the cancer cell death by blocking stress-activated protein kinase/c-Jun NH2-terminal kinase activation.

  2003cited by this paper
• Angiogenesis and apoptosis.

  2003cited by this paper
• The structure of Bcl‐w reveals a role for the C‐terminal residues in modulating biological activity

  2003cited by this paper
• Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs.

  2003cited by this paper
• p53 has a direct apoptogenic role at the mitochondria.

  2003cited by this paper
• Apoptosis: biochemical aspects and clinical implications.

  2002cited by this paper
• Solution structure of the antiapoptotic protein bcl-2

  2001cited by this paper
• Conditional deletion of the bcl-x gene from mouse mammary epithelium results in accelerated apoptosis during involution but does not compromise cell function during lactation.

  2001cited by this paper
• Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3

  2001cited by this paper
• Life-or-death decisions by the Bcl-2 protein family.

  2001cited by this paper
• Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL

  2001cited by this paper
• Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening.

  2001cited by this paper
• Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells.

  2000cited by this paper
• Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma

  2000cited by this paper
• Differential expression of bcl-w and bcl-x messenger RNA in the developing and adult rat nervous system.

  1999cited by this paper
• Bak BH3 Peptides Antagonize Bcl-xL Function and Induce Apoptosis through Cytochrome c-independent Activation of Caspases*

  1999cited by this paper
• Bcl-w expression in colorectal adenocarcinoma

  1999cited by this paper
• Bcl‐xL and Bcl‐2 expression in squamous cell carcinoma of the head and neck

  1999cited by this paper
• Drug Resistance in the Treatment of Cancer

  1998cited by this paper
• Bcl-2 family proteins

  1998cited by this paper
• Structure of Bcl-xL-Bak Peptide Complex: Recognition Between Regulators of Apoptosis

  1997cited by this paper
• Kaposi's sarcoma tumor cells preferentially express Bcl-xL.

  1996cited by this paper
• X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death

  1996cited by this paper
• Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA).

  1996cited by this paper
• bcl-w, a novel member of the bcl-2 family, promotes cell survival.

  1996cited by this paper

• Modifying inhibitor specificity for homologous enzymes by machine learning

  2025cites this paper
• Molecular modeling study of pyrrolidine derivatives as novel myeloid cell leukemia-1 inhibitors through combined 3D-QSAR, molecular docking, ADME/Tox and MD simulation techniques

  2023cites this paper
• Anticancer Profile of Rhodanines: Structure–Activity Relationship (SAR) and Molecular Targets—A Review

  2022cites this paper
• Novel hybrid pyrrolidinedione-thiazolidinones as potential anticancer agents: Synthesis and biological evaluation.

  2022cites this paper
• Synthesis, antimycobacterial, cytotoxicity, anti‐inflammatory, in silico studies and molecular dynamics of pyrazole‐embedded thiazolidin‐4‐one hybrids

  2022cites this paper
• DESIGN, SYNTHESIS AND ANTIMICROBIAL STUDIES OF 5-BENZYLIDENE SUBSTITUTED RHODANINE CONTAINING HETEROCYCLES

  2021cites this paper
• Synthesis of novel indole-thiazolidinone hybrid structures as promising scaffold with anticancer potential.

  2021cites this paper
• Synthesis, Physicochemical Properties, Drug Likeness, and Antitumor Activity of 2-[5-(4-Bromobenzylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-methylbutanoic Acid Esters and Amides

  2021cites this paper
• 5‐Arylidene‐2‐(4‐hydroxyphenyl)aminothiazol‐4(5H)‐ones with selective inhibitory activity against some leukemia cell lines

  2020cites this paper
• Synthesis and anti-leukemic activity of pyrrolidinedione-thiazolidinone hybrids

  2020cites this paper
• Synthesis of 5-enamine-4-thiazolidinone derivatives with trypanocidal and anticancer activity.

  2019cites this paper
• Synthesis and biological evaluation of tryptophan-derived rhodanine derivatives as PTP1B inhibitors and anti-bacterial agents.

  2019cites this paper
• Design, synthesis, evaluation, and molecular docking of ursolic acid derivatives containing a nitrogen heterocycle as anti-inflammatory agents.

  2018cites this paper
• Design, synthesis, and evaluation of novel ursolic acid derivatives as HIF-1α inhibitors with anticancer potential.

  2017cites this paper
• Design, synthesis and preliminary biological evaluation of indole-3-carboxylic acid-based skeleton of Bcl-2/Mcl-1 dual inhibitors.

  2017cites this paper
• Synthesis and anticancer activity of novel quinazolinone-based rhodanines

  2017cites this paper
• 5-Ene-4-thiazolidinones – An efficient tool in medicinal chemistry

  2017cites this paper
• Synthesis and evaluation of some novel N-substituted rhodanines for their anticancer activity

  2016cites this paper
• Antimycin-type depsipeptides: discovery, biosynthesis, chemical synthesis, and bioactivities.

  2016cites this paper
• Screening Novel SAHA Derivatives as Anti-lung Carcinoma Agents: Synthesis, Biological Evaluation, Docking Studies and Further Mechanism Research between Apoptosis and Autophagy.

  2015cites this paper
• Design, synthesis and preliminary bioactivity studies of 2-thioxo-4-thiazolidinone derivatives as Bcl-2 inhibitors.

  2015cites this paper
• The Synthesis and Anti-Bacterial Activities of N-carboxymethyl

  2014cites this paper
• Small molecule modulators of protein-protein interactions: selected case studies.

  2014cites this paper
• The Synthesis and Anti‐Bacterial Activities of N‐Carboxymethyl Rhodanines

  2014cites this paper
• Synthesis and biological evaluation of new rhodanine analogues bearing 2-chloroquinoline and benzo[h]quinoline scaffolds as anticancer agents.

  2014cites this paper
• Synthesis and evaluation of the antimicrobial activities of 3-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)-2-thioxothiazolidin-4-one derivatives.

  2014cites this paper
• Design and synthesis of L- and D-phenylalanine derived rhodanines with novel C5-arylidenes as inhibitors of HCV NS5B polymerase.

  2013cites this paper
• Rational design of apoptosis signal-regulating kinase 1 inhibitors: discovering novel structural scaffold.

  2013cites this paper
• Synthesis and antimicrobial evaluation of L-phenylalanine-derived C5-substituted rhodanine and chalcone derivatives containing thiobarbituric acid or 2-thioxo-4-thiazolidinone.

  2012cites this paper
• Discovery of potent and selective rhodanine type IKKβ inhibitors by hit-to-lead strategy.

  2012cites this paper
• Synthesis and antibacterial activity of novel 1,3-diphenyl-1H-pyrazoles functionalized with phenylalanine-derived rhodanines.

  2012cites this paper
• Bcl-2 targeted-therapy for the treatment of head and neck squamous cell carcinoma.

  2011cites this paper
• Structure–anticancer activity relationships among 4-azolidinone-3-carboxylic acids derivatives

  2010cites this paper
• The synthesis of phenylalanine-derived C5-substituted rhodanines and their activity against selected methicillin-resistant Staphylococcus aureus (MRSA) strains.

  2010cites this paper
• 5-Isopropylidene-3-ethyl rhodanine induce growth inhibition followed by apoptosis in leukemia cells.

  2010cites this paper
• Toward the development of innovative bifunctional agents to induce differentiation and to promote apoptosis in leukemia: clinical candidates and perspectives.

  2010cites this paper
• Novel naphthalimide derivatives as potential apoptosis-inducing agents: design, synthesis and biological evaluation.

  2009cites this paper
• Synthetic Inhibitors of Extended Helix–Protein Interactions Based on a Biphenyl 4,4′‐Dicarboxamide Scaffold

  2009cites this paper
• Non‐peptidic small molecule inhibitors against Bcl‐2 for cancer therapy

  2009cites this paper
• QSAR studies on anti-apoptotic Bcl-2 protein inhibitors

  2009cites this paper
• Behavioral effects of Bcl-2 deficiency: implications for affective disorders.

  2008cites this paper
• WL-276, an antagonist against Bcl-2 proteins, overcomes drug resistance and suppresses prostate tumor growth.

  2008cites this paper
• Principles of Molecularly Targeted Therapy: Present and Future

  2008cites this paper
• Small-molecule inhibitors of Bcl-2 family proteins as therapeutic agents in cancer.

  2008cites this paper
• Development of dimeric modulators for anti-apoptotic Bcl-2 proteins.

  2008cites this paper
• Structural studies of proteins in apoptosis and lipid signaling

  2008cites this paper